Skip to content

Epitope Diagnostics, Inc.

United Statesfrom the FDA registration address FDA FEI 3004185580

Devices
2
Registrations
FDA
FDA recalls
1
1 open since before 2021

At a glance

Counted by deviCERTS from registry records

Market reach

United States
FDA FEI, FDA recalls

What Epitope Diagnostics, Inc. makes

Epitope Diagnostics, Inc. manufactures fecal occult blood in vitro diagnostic (IVD) reagents, including the EDI™ CARE™ and CARE FECAL OCCULT BLOOD TEST, MODEL KT313.

The company's devices are classified as Class II and are listed in the FDA 510(k) and FDA UDI registries. Epitope Diagnostics, Inc. is based in the US.

AI-generated from registry data, 26 Oct 2026. Not verified by deviCERTS or the manufacturer.

Catalogue2

Newest first, rows 1-2 of 2

Company details

FDA FEI number
3004185580
DUNS number
144563058
Address
17034 Camino San Bernardo, SAN DIEGO, CA, 92127
Phone
858 693-7877

FDA recalls1

Recalls are matched to the firm by name. FDA recall data as of 22 Oct 2026.

FDA recall records list 1 recall initiated by Epitope Diagnostics, Inc., initiated on 2020-10-01. By recorded status: 1 ongoing. The reasons filed fall into these groups: manufacturing or quality process. A recall is often a precaution started by the manufacturer, and a count of records is not a verdict on a company.

Generated automatically from FDA recall records, as a summary of the records listed below. It describes what the records state and is not an assessment of this manufacturer.

Recalls initiated per year

  • 2017 0
  • 2018 0
  • 2019 0
  • 2020 1
  • 2021 0
  • 2022 0
  • 2023 0
  • 2024 0
  • 2025 0
  • 2026 0
  • 2020

    • 1 Oct 2020 Z-0426-2021 Class II Open since 2020 The use of deionized water rather than distilled water during the manufacturing process, may have resulted in accelerated decreased OD signals for the Positive Control value. Distribution: U.S Distribution.: NH, CO, OR, CA, FL, NY, MD, NJ, IL, NC, MI, TX, PA, MA, OH, NM, VA, SC, HI, and TN.

From the company website

Read 18 Oct 2026

Epitope Diagnostics Inc., a certified medical device manufacturer, specializes in niche immunoassays, offering ELISA kits, rapid tests, and antibodies.

From the manufacturer's own website, in their original language. Source

Frequently asked questions

How many devices does Epitope Diagnostics, Inc. have in the registry?

The registry currently lists 2 devices for Epitope Diagnostics, Inc.. Devices recorded under merged duplicate company entries are counted once.

Which registries list Epitope Diagnostics, Inc.'s devices?

Among its 2 most recently registered devices, Epitope Diagnostics, Inc. has devices listed in FDA 510(k) (1 device) and FDA GUDID (1 device). A device can be listed in more than one registry, so these counts overlap.

What risk classes do Epitope Diagnostics, Inc.'s devices fall under?

Among its 2 most recently registered devices, the classes recorded for Epitope Diagnostics, Inc.'s devices are Class II. Each device page shows its own class and authorisation.

Are there FDA recall records for Epitope Diagnostics, Inc.?

FDA recall records list 1 recall initiated by Epitope Diagnostics, Inc., the most recent initiated on 2020-10-01. 1 of them is recorded as ongoing. A recall is often a precaution started by the manufacturer; the records say nothing about the company's overall record.

What are the newest devices from Epitope Diagnostics, Inc. in the registry?

The most recently registered devices listed for Epitope Diagnostics, Inc. include EDI™ CARE™ KT-313 and CARE FECAL OCCULT BLOOD TEST, MODEL KT313.

Generated automatically from registry data and not verified by a human reviewer.